2 Space Stocks That Could Double in 2027 (Hint: Neither of Them Is SpaceX)

Redwire is expanding its Huntsville campus by 164,000 square feet to increase manufacturing and engineering capacity for space infrastructure and defense systems, supporting its positioning as a steadier space-sector investment. Rocket Lab's higher-risk upside hinges on its reusable medium-lift Neutron rocket reaching a targeted first launch within the next 12 months and on the planned Iridium acquisition, expected to close in mid-2027 pending regulatory approval. The article argues that both companies could potentially double by 2027 as global space and defense spending grows, though execution risks are materially higher for Rocket Lab.

Analysis

The key valuation divergence is recurring defense/space-systems revenue versus launch optionality. RDW should screen more like a subscale defense electronics and mission-systems supplier, where incremental manufacturing utilization can drive outsized gross-margin improvement; the relevant comparables are not pure launch names but KBR, LHX, NOC and BWXT. Its principal risk is that added capacity precedes funded awards, turning a defense-growth narrative into fixed-cost absorption pressure over the next 2-4 quarters.

RKLB's upside is increasingly a capital-allocation and execution question rather than a simple launch-demand story. A successful medium-lift program could rerate the company toward vertically integrated space primes, but schedule slips would likely require additional capital, extend negative free-cash-flow duration, and compress the premium multiple; the first meaningful de-risking milestones are engine qualification, pad readiness and disclosed customer backlog over the next 6-12 months. The reported IRDM transaction is sufficiently consequential that it should not be traded without confirming definitive merger documents, financing terms, regulatory filings and pro forma leverage; if unverified, it is a material misinformation risk rather than a catalyst.

Consensus may underappreciate that government satellite procurement is a crowded supply chain: satellite-bus and payload awards benefit RKLB and RDW, but prime budgets also flow to LHX, NOC, RTX and BAE Systems. Conversely, lower launch costs and more frequent access to orbit expand downstream demand for components, solar power, avionics and mission operations, potentially favoring RDW even if it never captures launch economics. Near-term retail enthusiasm is not enough to support a durable rerating absent bookings conversion and gross-margin evidence, making this a selective, catalyst-driven space allocation rather than a sector-beta trade.

Key Decisions for Investors

• Maintain a modest long RDW only after confirming funded backlog and quarterly book-to-bill above 1.0x; target a 6-12 month margin/utilization rerating, with thesis invalidated by two quarters of declining backlog or gross-margin deterioration following the capacity buildout.
• Treat RKLB as an event-driven long rather than a core holding: initiate or add only around independently verified Neutron hardware/qualification milestones, sized for binary execution risk. Exit/reduce on a material schedule revision or a financing plan that materially increases expected dilution; use a 9-15 month horizon rather than underwriting first-flight success today.
• Do not position in IRDM on the purported acquisition until SEC filings establish transaction consideration, closing conditions and leverage. Create an alert for an 8-K/merger agreement; a cash-heavy structure or weak regulatory visibility would be negative for RKLB's financing capacity even if strategically attractive.
• For lower-volatility defense exposure, pair long RDW against a small short RKLB only if RKLB materially outperforms ahead of unverified Neutron or M&A claims; the trade expresses execution-risk dispersion while retaining space/defense spending exposure. Cover if RKLB reports contracted medium-lift backlog or a clearly funded, on-schedule first-flight plan.